Summary
73 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 14% a year over the last 3 years.
- It has been profitable 6 years in a row.
What to watch
- The share price is above the Bulios Fair Price.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 36.0 USD for 1 USD of yearly profit. Over the last five years it was 46.2 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
Revenue grew by 8.6% a year over 5 years. Over the last 3 years it grew by 11% a year. Earnings per share grew by 14% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 76 USD
- Sales and administration 8.5 USD
- Taxes and other 3.6 USD
- Net profit 12 USD
Net profit, industry median (Insurance - Brokers) 10 USD
Out of every 100 USD of revenue, 12 USD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
Fiscal year 2026By product
- Patient Management Services 62%
- Network Solutions Services 38%
By region
The company reports no revenue by region.
Patient Management Services brings in 62% of revenue. Network Solutions Services grew fastest, by 15% a year.
Segments in detail